Background Network meta-analysis (NMA) allows for the estimation of comparative effectiveness of treatments that have not been studied in head-to-head trials; however, relative treatment effects for all interventions can only be derived where available evidence forms a connected network. Head-to-head evidence is limited in many disease areas, regularly resulting in disconnected evidence structures where a large number of treatments are available. This is also the case in the evidence of treatments for relapsed or refractory multiple myeloma. Methods Randomised controlled trials (RCTs) identified in a systematic literature review form two disconnected evidence netw...
Partial funding for Open Access provided by the UMD Libraries' Open Access Publishing Fund.Network ...
Despite major therapeutic advancements, multiple myeloma (MM) is still incurable and relapsed/refrac...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...
Background: Network meta-analysis (NMA) allows for the estimation of comparative effectiveness of tr...
BACKGROUND: Network meta-analysis (NMA) allows for the estimation of comparative effectiveness of tr...
A network meta-analysis allows a simultaneous comparison between treatments evaluated in randomised ...
In multivariate network meta‐analysis (NMA), the piecemeal nature of the evidence base means that th...
Background: There are many circumstances under which networks of evidence may be ‘disconnected’ and ...
Importance: Several trials demonstrated the impact of novel agent-based maintenance in newly diagnos...
Background: Previous network meta-analyses combined studies of immunomodulatory drug (IMiD)–containi...
Network meta-analysis (NMA) is an important aspect of evidence synthesis in a clinical setting, as i...
The treatment scenario for newly-diagnosed transplant-ineligible multiple myeloma patients (NEMM) is...
Xian-Wu Luo,1 Xue-Qing Du,2 Jie-Li Li,2 Xiao-Ping Liu,3,4 Xiang-Yu Meng3,4 1Department of Health Man...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...
Decision making for patients with multiple myeloma (MM) not transplant eligible (NTE) is complicated...
Partial funding for Open Access provided by the UMD Libraries' Open Access Publishing Fund.Network ...
Despite major therapeutic advancements, multiple myeloma (MM) is still incurable and relapsed/refrac...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...
Background: Network meta-analysis (NMA) allows for the estimation of comparative effectiveness of tr...
BACKGROUND: Network meta-analysis (NMA) allows for the estimation of comparative effectiveness of tr...
A network meta-analysis allows a simultaneous comparison between treatments evaluated in randomised ...
In multivariate network meta‐analysis (NMA), the piecemeal nature of the evidence base means that th...
Background: There are many circumstances under which networks of evidence may be ‘disconnected’ and ...
Importance: Several trials demonstrated the impact of novel agent-based maintenance in newly diagnos...
Background: Previous network meta-analyses combined studies of immunomodulatory drug (IMiD)–containi...
Network meta-analysis (NMA) is an important aspect of evidence synthesis in a clinical setting, as i...
The treatment scenario for newly-diagnosed transplant-ineligible multiple myeloma patients (NEMM) is...
Xian-Wu Luo,1 Xue-Qing Du,2 Jie-Li Li,2 Xiao-Ping Liu,3,4 Xiang-Yu Meng3,4 1Department of Health Man...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...
Decision making for patients with multiple myeloma (MM) not transplant eligible (NTE) is complicated...
Partial funding for Open Access provided by the UMD Libraries' Open Access Publishing Fund.Network ...
Despite major therapeutic advancements, multiple myeloma (MM) is still incurable and relapsed/refrac...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...